arrow
A

Aldo Clerico

University of Padua
H指数:53
被引数:9,609

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Analytical characteristics and performance of a new hs-cTnI method: a multicenter-study: On behalf of the Study Group on Cardiac Biomarkers of the Italian Societies of Laboratory Medicine SIBioC and ELAS
2025-01-070
PRE
Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers. A consensus document by the Inter-Society Study Group on Cardiac Biomarkers of the Italian Societies of Clinical Biochemistry: European Ligand Assay Society (ELAS), Italian section; Societa Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC); Societa Italiana di Patologia Clinica e Medicina di Laboratorio (SIPMel)

主要非心脏手术患者心血管风险评估: 心脏特异性生物标志物的作用.意大利临床生物化学学会心脏生物标志物学会间研究小组的共识文件: 欧洲配体测定学会 (ELAS),意大利分会; 意大利生物化学学会 (SIBioC); 意大利Patologia Clinica e Medicina di Laboratorio (SIPMel)

2022-07-209
OA
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Societa Italiana di Biochimica Clinica), and SIPMeL (Societa Italiana di Patologia Clinica e Medicina di Laboratorio)

在急诊科使用高灵敏度心肌肌钙蛋白对无持续性ST段抬高的急性心肌梗死 (NSTEMI) 进行早期治疗和排除治疗意大利与意大利学会ELAS相关的心脏生物标志物研究组的专家意见文件 (欧洲配体测定协会,意大利科) 、SIBIoC (意大利生物化学临床学会) 和SIPMeL (意大利临床学会和医学实验室学会)

2021-12-2013
OA